swish30

CLDX - Fibonacci setup ahead of potential clinical data

Long
NASDAQ:CLDX   Celldex Therapeutics, Inc.
Waiting on an update on Phase 2 trials in melanoma patients expected in Q4. Stock could rally from Fibonacci setup after the conference.

Buy zone: 2.70
Profit zone: 3.00 or higher
Stop zone: 2.55 or lower

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.